Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “HAIC(Hepatic Artery Infusion Chemotherapy)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Looking for participantsNCT06904170
What this trial is testing

Durvalumab and Tremelimumab With or Without Hepatic Arterial Infusion of Chemotherapy in Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
UNICANCER 196
Testing effectiveness (Phase 2)Looking for participantsNCT06031285
What this trial is testing

Perioperative Sintilimab Plus Bevacizumab Biosimilar and TACE-HAIC for HCC Patients With PVTT: A Phase-2 Clinical Trial

Who this might be right for
Hepatocellular Carcinoma
Sun Yat-sen University 43
Testing effectiveness (Phase 2)Active Not RecruitingNCT03869034
What this trial is testing

HAIC Combined with PD-1 Inhibitor in Potentially Resectable Locally Advanced HCC

Who this might be right for
Hepatocellular Carcinoma
Sun Yat-sen University 40
Large-scale testing (Phase 3)UnknownNCT03469479
What this trial is testing

Neoadjuvant HAIC for Resectable Hepatocellular Carcinoma Beyond Milan Criteria

Who this might be right for
Hepatocellular Carcinoma
Sun Yat-sen University 252
Not applicableUnknownNCT05233358
What this trial is testing

HAIC Combined With Second-line "Target Immunity" for HCC With TACE Standard Treatment Low Response or Failure

Who this might be right for
Hepatocellular Carcinoma
The Central Hospital of Lishui City 176
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07432568
What this trial is testing

Liposomal Irinotecan Plus 5-FU/LV HAIC With Lenvatinib and a PD-1 Inhibitor in Advanced ICC

Who this might be right for
Intrahepatic Cholangiocarcinoma
Tianjin Medical University Cancer Institute and Hospital 30
Testing effectiveness (Phase 2)Looking for participantsNCT05751343
What this trial is testing

Atezolizumab and Bevacizumab Plus TACE-HAIC for Unresectable Advanced HCC: a Phase 2 Clinical Trial

Who this might be right for
Hepatocellular Carcinoma
Sun Yat-sen University 55
Testing effectiveness (Phase 2)Study completedNCT04044313
What this trial is testing

HAIC Plus Lenvatinib and Toripalimab for Advanced HCC

Who this might be right for
Hepatocellular Carcinoma
Shi Ming 36
Not applicableStudy completedNCT05489692
What this trial is testing

HAIC Plus Targeted Therapy and/or PD-1 Inhibitors for Unresectable Intrahepatic Cholangiocarcinoma

Who this might be right for
Intrahepatic Cholangiocarcinoma
Sun Yat-sen University 43
Not applicableStudy completedNCT06435013
What this trial is testing

Lenvatinib vs Bevacizumab Plus ICIs and HAIC in Unresectable HCC

Who this might be right for
Hepatocellular CarcinomaLenvatinib
Sun Yat-sen University 208
Testing effectiveness (Phase 2)Study completedNCT03048123
What this trial is testing

HAIC Versus TACE for Large and Unresectable Hepatocellular Carcinoma Staged BCLC A/B

Who this might be right for
Hepatocellular Carcinoma
Sun Yat-sen University 79
Testing effectiveness (Phase 2)UnknownNCT04191889
What this trial is testing

A Trial of Hepatic Arterial Infusion Combined With Apatinib and Camrelizumab for C-staged Hepatocellular Carcinoma in BCLC Classification

Who this might be right for
C-staged Hepatocellular Carcinoma in BCLC Classification
Sun Yat-sen University 47
Not applicableStudy completedNCT06631326
What this trial is testing

HAIC in Combination With PD-1 Inhibitors and Lenvatinib for High Tumor Burden Advanced HCC (CHANCE2416)

Who this might be right for
HCC - Hepatocellular CarcinomaHepatic Arterial Infusion ChemotherapyBCLC Stage C Hepatocellular Carcinoma+2 more
First Hospital of China Medical University 244
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07587034
What this trial is testing

HAIC-TACE Plus Apatinib and Camrelizumab for Liver Cancer

Who this might be right for
Liver Cancer
Shanghai Zhongshan Hospital 315
Testing effectiveness (Phase 2)UnknownNCT06001567
What this trial is testing

Avatrombopag for HCC Patients With Thrombocytopenia Who Intend to Undergo TACE and/or HAIC

Who this might be right for
ThrombocytopeniaHepatocellular Carcinoma
Second Affiliated Hospital of Guangzhou Medical University 30
Not applicableLooking for participantsNCT07436845
What this trial is testing

Impact of Emotional Status on Prognosis of Patients With BCLC Stage B/C Hepatocellular Carcinoma Undergoing Hepatic Arterial Infusion Chemotherapy Combined With Targeted and Immunotherapy

Who this might be right for
Hepatocellular Carcinoma (HCC)Emotional DistressHAIC(Hepatic Artery Infusion Chemotherapy)+2 more
Nanfang Hospital, Southern Medical University 90
Large-scale testing (Phase 3)Looking for participantsNCT06492395
What this trial is testing

Lenvatinib Plus DEB-TACE and HAIC vs. Lenvatinib Plus DEB-TACE for Large HCC With PVTT

Who this might be right for
Hepatocellular Carcinoma Non-resectable
Second Affiliated Hospital of Guangzhou Medical University 178
Large-scale testing (Phase 3)UnknownNCT04961970
What this trial is testing

HAIC With FOLFOX Versus Systemic Chemotherapy With GP for Unresectable ICC

Who this might be right for
Intrahepatic Cholangiocarcinoma
Shi Ming 188
Post-approval studies (Phase 4)UnknownNCT05124002
What this trial is testing

Recombinant Human Adenovirus Type 5 Plus HAIC of FOLFOX for Intrahepatic Cholangiocarcinoma

Who this might be right for
Cholangiocarcinoma, Intrahepatic
Beijing Tsinghua Chang Gung Hospital 66
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07119931
What this trial is testing

A Clinical Study Evaluating HAIC Combined With Iparomlimab and Tuvonralimab Injection Plus Bevacizumab in Patients With Initially Potentially Resectable Hepatocellular Carcinoma (ITBHaic Study)

Who this might be right for
HCC
Tianjin Medical University Cancer Institute and Hospital 34
Next Page